SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Laser Vision Centers, Inc. (NASDAQ: LVCI) -- Ignore unavailable to you. Want to Upgrade?

To: Stanley L. Freedman who wrote (142)6/12/1998 11:45:00 AM
From: MGV  Respond to of 413
 
Stanley, This stock is hanging very tough in a down market. Relative strength is very good. The procedure numbers recently published by LVRCF suggest the trend to explosive growth in the industry is continuing.

Anecdotal evidence (talking to the local PRK surgeons) supports a view that PRK procedures are ramping up geometrically. In short, all indications are that this company will meet or exceed earnings estimates. - Mark



To: Stanley L. Freedman who wrote (142)6/12/1998 2:29:00 PM
From: Jim Mac  Read Replies (1) | Respond to of 413
 
Expect analysts to put LVCI's FY2000/CY99 EPS (fully-taxed) at $1.00 as reported, $1.50 on cash basis --LVCI has a lot of dep/amort. Hyperopia should add a lot, with likely 50,000 procedures done next year, 5000-10,000 by LVCI.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News